2019 AliquantumRx Inc. Signs a Licensing Agreement with Johns Hopkins Technology Ventures
AliquantumRx Inc. has entered into a licensing agreement with JHTV for all of their IP rights to further develop, market and otherwise commercialize “Macrolide for Liver Stage Malaria”. The license is not a worldwide exclusive as another group jointly worked with JHU on the patent and retained their rights. “We are happy that after almost […]